CRL

Charles River Laboratories International, …

259.06 USD
+0.13 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Charles River Laboratories International, … stock is up 19.06% since 30 days ago. The next earnings date is May 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 79.17% of the previous 23 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 10 PUTs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
28 Feb 15:15 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:20 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:20 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:20 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:27 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:30 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:38 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:38 17 Jan, 2025 260.00 PUT 10 0
28 Feb 15:39 17 Jan, 2025 260.00 PUT 10 0
01 Mar 15:34 19 Jul, 2024 260.00 PUT 73 2

About Charles River Laboratories International, …

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services. The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies. The Manufacturing segment provides in vitro testing of sterile and non-sterile pharmaceuticals and consumer products.

  • Evercore Partners
    Thu Feb 15, 13:31
    buy
    confirm
  • UBS
    Thu Feb 15, 11:52
    buy
    confirm
  • Citigroup
    Thu Feb 15, 11:16
    hold
    confirm
  • Baird
    Thu Feb 15, 10:02
    buy
    confirm
  • JP Morgan
    Thu Feb 15, 09:38
    buy
    confirm
  • Guggenheim
    Thu Feb 15, 08:01
    hold
    downgrade